Abstract: A medication infusion device includes a pre-filled medication container containing sterile liquid medication. The medication infusion device also includes an infusion needle and the infusion needle has a distal end, wherein the distal end of the infusion needle is movable relative to the pre-filled medication container. There is a pierceable elastomeric component arranged at the distal end of the infusion needle to define a sterile environment, and this sterile environment is shared by the pre-filled medication container and the distal end of the infusion needle. The distal end of the infusion needle is embedded in a pierceable elastomeric component in order to keep the infusion needle enclosed in the sterile environment and prevent medication from flowing out of the infusion needle.

Abstract: Provided are antibodies that specifically bind to T-cell immunoglobulin domain and mucin domain 3 (Tim-3). The anti-Tim-3 antibodies can be used to treat, prevent or diagnose immune, cancerous, infectious diseases or other pathological disorders that may be modulated by Tim-3-mediated functions.

Abstract: A fasting mimicking diet package providing daily meal portions for a predetermined number of days is provided. The fasting mimicking diet package includes a kale cracker composition, a first vegetable broth composition, a mushroom soup composition, a tomato soup composition, a quinoa-containing minestrone soup composition, a bean-containing minestrone soup composition, and a pumpkin soup composition. Characteristically, the daily meal portions are packaged into meal servings or into a total daily serving to be divided into meals.

Abstract: A medication infusion device includes a medication container containing liquid medication; an infusion needle; and a reciprocating pump having a pump chamber. The liquid medication is withdrawn from the medication container into the pump chamber during suction operation of the reciprocating pump, and the liquid medication is dispensed out of the pump chamber through the infusion needle during dispensing operation of the reciprocating pump. There are also mechanisms preventing liquid from flowing through the infusion needle during suction operation of the reciprocating pump and preventing liquid from flowing back into the medication container during dispensing operation of the reciprocating pump. The medication infusion device may further include a microcontroller to control medication infusion volume and rate.

Abstract: The present application discloses a needle for repairing an alignment layer on a liquid crystal display substrate. The needle includes a needle tip; and a flexible material coating surrounding the needle tip.

Abstract: Disclosed are systems for applying materials to components. The system comprises a tool operable for transferring a portion of a material from a supply of the material to a component. A first portion of the tool may be configured for cutting along a side or edge of the portion of the material. A second portion of the tool may be configured for tamping, pressing, or pushing against the portion of the material to cause uncut sides or edges of the portion of the material attached to the supply of the material to be torn, severed, detached, or separated from the supply of the material.

Abstract: The invention proposes a method of separating hemicellulose through efficient pretreatment of fibrous biomass materials. Fibrous biomass materials are first pretreated by the slurry method: the fibrous biomass materials are milled through ball mills and sieved to obtain fibrous biomass material powder, and the powder is mixed with water at room temperature to obtain slurry premixed solution of the fibrous biomass material powder. Through regulation and control of the reaction temperature, the time and the water amount, efficient hydrothermal removal of hemicellulose from the fibrous biomass material powder is realized. After the mixed solution is filtered, the filtrate is subject to gradient sedimentation to separate hemicellulose with low dispersity, and the sediment is then dried before storage. After the filter residue is mixed with polar aprotic solvent and water, and heated and stirred in a pressurized reactor, high-purity cellulose is obtained through filtering and separation.

Abstract: Provided are antibodies that specifically bind to TIGIT (T cell immunoreceptor with Ig and ITIM domains, WUCAM or Vstm3) and inhibit Tigit-mediated cellular signaling and activities in immune cells. The anti-TIGIT antibodies can be used to treat or diagnose cancer, infectious diseases or other pathological disorders that may be modulated by Tigit-mediated functions.

Abstract: Provided are antibodies that specifically bind to T-cell immunoglobulin domain and mucin domain 3 (Tim-3). The anti-Tim-3 antibodies can be used to treat, prevent or diagnose immune, cancerous, infectious diseases or other pathological disorders that may be modulated by Tim-3-mediated functions.

Abstract: Disclosed herein is a method for the prevention, delay of progression or treatment of cancer in a subject, comprising administering to the subject in need thereof a PARP inhibitor, particularly, (R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one, a sesqui-hydrate thereof, or a pharmaceutically acceptable salt thereof, in combination with an immune checkpoint inhibitor or a chemotherapeutic agent. Also, disclosed a pharmaceutical combination comprising a PARP inhibitor, particularly, (R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one, a sesqui-hydrate thereof, or a pharmaceutically acceptable salt thereof, in combination with an immune checkpoint inhibitor, or a chemotherapeutic agent and the use thereof.

Abstract: Provided is a data security sharing method for multiple edge nodes to operate in a collaboration mode under an industrial cloud environment. The method includes: firstly, edge nodes that need collaborative computing separately applying for a shared key to an authority center; secondly, the authority center generating a shared key and issuing the key to each of the edge nodes applying for participation in the collaborative computing; again, the edge nodes combining industrial characteristics to generate an interference factor set, and adding different interference factors for different types of data; then, the data of the edge nodes is implemented with improved homomorphic encryption and is uploaded to an industrial cloud platform; and finally, the industrial cloud platform performing homomorphic analysis and computing on the data uploaded by each of the edge nodes, and issuing the data back to each of the edge nodes.

Abstract: A positioning structure of a clamper of a threading machine for a racket contains: a rack, an engagement protrusion, an operation member, and two springs. A fixing holder is erected on a support plate of the threading machine, and the rack includes multiple first teeth, the fixing holder includes an accommodation chamber with an opening. The engagement protrusion is received in the accommodation chamber and includes a toothed extension on which multiple second teeth are formed. The engagement protrusion further includes a recess and an abutting fence. The operation member includes a drive portion and a push portion. The two springs are mounted on a top of the engagement protrusion, and two ends of each spring abut against the engagement protrusion and the fixing holder respectively so that each spring forces the engagement protrusion to engage with the rack.

Abstract: Disclosed are systems for applying materials to components. The system comprises a tool operable for transferring a portion of a material from a supply of the material to a component. A first portion of the tool may be configured for cutting along a side or edge of the portion of the material. A second portion of the tool may be configured for tamping, pressing, or pushing against the portion of the material to cause uncut sides or edges of the portion of the material attached to the supply of the material to be torn, severed, detached, or separated from the supply of the material.

Abstract: Disclosed herein is a method for the prevention, delay of progression or treatment of cancer in a subject, comprising administering to the subject in need thereof a Btk inhibitor, particularly, (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof, in combination with an immune checkpoint inhibitor or a targeted therapy agent. Also, disclosed a pharmaceutical combination comprising a Btk inhibitor, particularly, (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof, in combination with an immune checkpoint inhibitor, or a targeted therapy agent and the use thereof.

Abstract: The present invention relates to an improved KNN-based 6LoWPAN network intrusion detection method. The present invention selects quantifiable security features which can reflect a self-security state of network elements of a 6LoWPAN network for training, and establishes a 6LoWPAN network feature space. The present invention assigns the weights to the features and transfers zero points, to alleviate the bias caused by large and small impact factors and simplify calculation; realizes construction and update of a state data table of network elements by extracting the feature data of network elements in real time, thus forming a normal contour updated according to the real-time state of the network in the feature space of the 6LoWPAN network based on the clustering effect of a KNN algorithm; and the present invention improves the KNN algorithm and redefines a basis for judging the invasion, to meet the requirements for 6LoWPAN network intrusion detection.

Abstract: Disclosed herein is a pharmaceutical combination for use in the prevention, delay of progression or treatment of cancer, wherein the pharmaceutical combination exhibits a synergistic efficacy. The pharmaceutical combination comprises a humanized antagonist monoclonal antibody against PD- and a RAF inhibitor. Also disclosed herein is a combination for use in the prevention, delay of progression or treatment of cancer in a subject, comprising administering to the subject a therapeutically effective amount of a humanized antagonist monoclonal antibody against PD-1 and a therapeutically effective amount of a RAF inhibitor.

Abstract: A system and the method of use for processing a cell therapy product includes a centrifugation container and a rotor generating centrifugal field that extends to the centrifugation container. The centrifugation container has a substantially cylindrically shaped container body and a movable plunger rod. The container body contains cell suspension and the movable plunger rod is configured to have a mixing blade at the end of the movable plunger rod contacting the cell suspension in the container body. The mixing blade on the movable plunger rod generates mixing force applied to the cell suspension when the movable plunger rod is rotated around axis of the container body. The end of the movable plunger rod contacting the cell suspension is also movable in the container body along longitudinal direction of the container body when withdrawing and expelling fluid in and out of the centrifugation container body.

Abstract: A medication injection device comprising a medication container to contain medication; a connector provided with a blocking feature; a push rod having a plurality of teeth disposed along the length, and a spring biasing against the push rod to move proximally. The spring can be compression spring, extension spring, torsion spring, or constant force spring. By enabling or disabling engagement between the blocking feature on the connector and the tooth on the push rod, the push rod is either prevented from moving distally or allowed to move distally. The medication is drawn into the medication container when the push rod moves proximally and the medication is dispensed out of the medication container when the push rod moves distally.

Abstract: A positioning structure of a clamper of a threading machine for a racket contains: a rack, an engagement protrusion, an operation member, and two springs. A fixing holder is erected on a support plate of the threading machine, and the rack includes multiple first teeth, the fixing holder includes an accommodation chamber with an opening. The engagement protrusion is received in the accommodation chamber and includes a toothed extension on which multiple second teeth are formed. The engagement protrusion further includes a recess and an abutting fence. The operation member includes a drive portion and a push portion. The two springs are mounted on a top of the engagement protrusion, and two ends of each spring abut against the engagement protrusion and the fixing holder respectively so that each spring forces the engagement protrusion to engage with the rack.

Abstract: The present application discloses a needle for repairing an alignment layer on a liquid crystal display substrate. The needle includes a needle tip; and a flexible material coating surrounding the needle tip.